Merck & Co., Inc.
- SEC CIK
- 0000310158
- Latest filing
- Aug 7, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 12
- −1 vs. Q3 2025
- Portfolio value
- $276.3M
- +$48.2M (+21.2%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PSNLPersonalis, Inc. | COM | 14,044,943 | $111.8M | 40.5% | 00.0% | Unchanged | History |
| MRNAModerna, Inc. | Stock | 2,308,190 | $68.1M | 24.6% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 772,165 | $60.1M | 21.7% | 00.0% | Unchanged | History |
| Entrada Therapeutics Inc29384C908 | CALL | 1,739,768 | $17.9M | 6.5% | 00.0% | Unchanged | – |
| EVAXEvaxion A/S | COM | 1,214,126 | $5.79M | 2.1% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 3,545,719 | $5.53M | 2.0% | 00.0% | Unchanged | History |
| STROSutro Biopharma, Inc. | COM | 272,351 | $3.15M | 1.1% | 00.0% | UnchangedConverted for a 1-for-10 split | History |
| VRDNViridian Therapeutics, Inc. | COM | 93,414 | $2.91M | 1.1% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 1,483,758 | $949.9K | 0.3% | 00.0% | Unchanged | History |
| CARMCarisma Therapeutics Inc. | COM | 1,473,240 | $63.3K | <0.1% | 00.0% | Unchanged | History |
| NEUPNeuphoria Therapeutics Inc. | COM | 10,027 | $38.9K | <0.1% | 00.0% | Unchanged | History |
| HURATuHURA Biosciences, Inc. | COM | 13,950 | $10.6K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q3 2025 (1)
Positions held at the end of Q3 2025 that are gone from this filing.